PATENT CLAIM ANALYSIS

Application Number: 16193045
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["424", "133100"]

Abstract:
The present invention relates to methods for treating cancer with apilimod and related compositions and methods.

Claim (Index 26):
The method of  claim 24 , wherein the non-Hodgkin's B cell lymphoma is selected from diffuse large B cell lymphoma (DLBCL), follicular lymphoma, Burkitt's lymphoma, mediastinal B cell lymphoma, and mantle cell lymphoma.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 98.0
- Lexical Diversity: 1.13333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15113154', '15213829', '15524844', '15809445', '13968202']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7839833756769014
- 35 USC 102 Novelty (BERT): 0.6431977402863849
- Combined Prediction Score: 0.7699048121378498
- Mean Citation Score: 434.80035600000014
- Max Citation Score: 692.62885
- Similarity Product: 556.5941585755378

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test